Hemizygous deletion of &lt;i&gt;CDKN2A/B&lt;/i&gt; in &lt;i&gt;IDH&lt;/i&gt;-mutated glioma: Prognostic impact when adjusting for clinical factors. This evidence concerns the gene CDKN2A and central nervous system cancer.